Zhongchao Inc. Announces Successful Medication Assistance Services for Over 7,000 SLE Patients with Approximately 130,000 Units of Medications
Zhongchao Inc. - Class A Ordinary Shares (ZCMD)
Company Research
Source: PR Newswire
SHANGHAI, March 12, 2024 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services for patients with cancer and other major diseases, today announced that Shanghai Zhongxin Medical Technology Co., Ltd. ("Zhongxin"), of which Zhongchao consolidates the operations and financial results through a series of contractual arrangements, had successfully provided medication assistance services to over 7,000 low-income patients suffering from Systemic Lupus Erythematosus (SLE) and reduced their financial challenges associated with long-term treatment.SLE is a chronic inflammatory autoimmune disease that affects multiple organs. Zhongxin offered Titazepam and Belimumab, medications used for SLE treatments, to qualified low-income SLE patients for free through its patient aid projects. Leveraging its self-developed technical service platform, Zhongxin facilitated connections among hospitals, pharmacies, corporation
Show less
Read more
Impact Snapshot
Event Time:
ZCMD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ZCMD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ZCMD alerts
High impacting Zhongchao Inc. - Class A Ordinary Shares news events
Weekly update
A roundup of the hottest topics
ZCMD
News
- Zhongchao Full Year 2023 Earnings: US$4.35 loss per share (vs US$1.13 loss in FY 2022) [Yahoo! Finance]Yahoo! Finance
- INDO, IPDN and GSUN among mid-day movers [Seeking Alpha]Seeking Alpha
- Galectin Therapeutics, Titan Pharmaceuticals, Outset Medical among healthcare movers [Seeking Alpha]Seeking Alpha
- Zhongchao Inc. Announces Successful Medication Assistance Services for Over 7,000 SLE Patients with Approximately 130,000 Units of Medications [Yahoo! Finance]Yahoo! Finance
- Zhongchao Inc. Announces 1-for-10 Share Consolidation [Yahoo! Finance]Yahoo! Finance
ZCMD
Sec Filings
- 4/30/24 - Form 20-F
- 3/18/24 - Form 6-K
- 2/29/24 - Form 6-K
- ZCMD's page on the SEC website